Tag
Medicare is considering ending its breakthrough device payment pathway, which currently fast-tracks reimbursement for FDA-designated novel medical devices. Removal would push manufacturers into standard, slower coverage reviews, undermining the commercial case for early-stage medtech innovation. No timeline for a final
A new report puts the combined unfunded liability of US Medicare and Social Security at $130 trillion, underscoring a structural gap between promised benefits and committed funding. The shortfall, driven by demographic shifts and healthcare cost inflation, signals that benefit adjustments or revenue changes are likely
Tag
Medicare is considering ending its breakthrough device payment pathway, which currently fast-tracks reimbursement for FDA-designated novel medical devices. Removal would push manufacturers into standard, slower coverage reviews, undermining the commercial case for early-stage medtech innovation. No timeline for a final
2mo ago · 1 min · Policy & Government
A new report puts the combined unfunded liability of US Medicare and Social Security at $130 trillion, underscoring a structural gap between promised benefits and committed funding. The shortfall, driven by demographic shifts and healthcare cost inflation, signals that benefit adjustments or revenue changes are likely
2mo ago · 1 min · Policy & Government
— End of feed —